High-sensitivity cardiac troponin T predicts mortality after hospitalization for community-acquired pneumonia

Stefan M T Vestjens1, Simone M C Spoorenberg1, Ger T Rijkers2,3

  • 1Department of Internal Medicine, St. Antonius Hospital, Nieuwegein, The Netherlands.

Respirology (Carlton, Vic.)
|February 22, 2017
PubMed

Insights

High-sensitivity cardiac troponin T (cTnT) levels on admission predict mortality in community-acquired pneumonia (CAP) patients. Elevated cTnT identifies patients at higher risk for both short-term and long-term death.

Area of Science:

  • Cardiology
  • Pulmonology
  • Critical Care Medicine

Background:

  • Community-acquired pneumonia (CAP) hospitalization is associated with high mortality.
  • Cardiovascular disease is strongly linked to CAP mortality.
  • Prognostic markers for CAP mortality require further investigation.

Purpose of the Study:

  • To evaluate the prognostic value of high-sensitivity cardiac troponin T (cTnT) for mortality in hospitalized CAP patients.
  • To determine if cTnT levels improve risk stratification beyond existing pneumonia severity scores.

Main Methods:

  • Assessed cTnT levels on admission in 295 CAP patients from a randomized trial.
  • Measured short-term (30-day) and long-term (4.1-year) mortality.
  • Compared predictive accuracy of cTnT alone and in combination with Pneumonia Severity Index (PSI) class.

Main Results:

  • Elevated cTnT levels (≥14 ng/L) were found in 45% of patients.
  • Patients with elevated cTnT had significantly higher short- and long-term mortality.
  • cTnT combined with PSI class significantly improved short-term mortality prediction (AUC=0.903) versus PSI alone (AUC=0.818).
  • A cTnT cut-off of 28 ng/L independently predicted both short- and long-term mortality.

Conclusions:

  • Elevated admission cTnT levels are a potent predictor of mortality in hospitalized CAP patients.
  • cTnT offers valuable prognostic information, enhancing risk stratification for CAP.
  • Early identification of high-risk CAP patients using cTnT can inform clinical management.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.0K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
353
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
668
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
427